Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,841
Closed -$1,000K 353
2026
Q1
$1,000K Sell
2,841
-10
-0.4% -$3.56K 0.05% 176
2025
Q4
$933K Buy
+2,851
New +$904K 0.05% 173
2023
Q1
Sell
-789
Closed -$207K 342
2022
Q4
$207K Sell
789
-7,442
-90% -$1.99M 0.02% 325
2022
Q3
$1.85M Buy
+8,231
New +$2M 0.18% 138
2021
Q3
Sell
-11,177
Closed -$2.72M 350
2021
Q2
$2.72M Buy
11,177
+5,892
+111% +$1.45M 0.22% 130
2021
Q1
$1.31M Buy
+5,285
New +$1.26M 0.12% 196
2020
Q4
Sell
-5,836
Closed -$1.48M 350
2020
Q3
$1.48M Sell
5,836
-75
-1% -$18.6K 0.16% 128
2020
Q2
$1.39M Sell
5,911
-13,459
-69% -$3.07M 0.16% 132
2020
Q1
$3.93M Buy
19,370
+1,670
+9% +$365K 0.52% 54
2019
Q4
$4.27M Sell
17,700
-288
-2% -$63.5K 0.4% 81
2019
Q3
$3.5M Buy
17,988
+3,337
+23% +$641K 0.36% 88
2019
Q2
$2.7M Sell
14,651
-1,177
-7% -$211K 0.36% 80
2019
Q1
$3.02M Sell
15,828
-4,122
-21% -$787K 0.41% 74
2018
Q4
$3.88M Buy
+19,950
New +$3.89M 0.28% 66

Other funds holding AMGN

Sepio Capital's AMGN Position: Q2 2026 in Review

Sepio Capital sold out of Amgen (AMGN) in Q2 2026, closing a stake of 2,841 shares — an estimated $1,000K sold.

Sepio Capital first reported a position in AMGN in Q4 2018 and held it in 14 quarters. The position peaked at $4.27M in Q4 2019. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sepio Capital reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Sepio Capital sold 2,841 Amgen shares in Q2 2026, an estimated $1,000K.
  • Sepio Capital first reported a position in Amgen in Q4 2018 and held it in 14 quarters.
  • Sepio Capital's Amgen position peaked at $4.27M in Q4 2019.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.